Technical Analysis for MNK - Mallinckrodt plc

Grade Last Price % Change Price Change
grade B 29.64 -0.40% -0.12
MNK closed down 0.4 percent on Friday, September 21, 2018, on 1.13 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical MNK trend table...

Date Alert Name Type % Chg
Sep 21 Multiple of Ten Bearish Other 0.00%
Sep 21 Oversold Stochastic Weakness 0.00%
Sep 20 MACD Bearish Centerline Cross Bearish -0.40%
Sep 20 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.40%
Sep 20 Narrow Range Bar Range Contraction -0.40%
Sep 20 Oversold Stochastic Weakness -0.40%
Sep 19 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.13%
Sep 19 Narrow Range Bar Range Contraction -0.13%
Sep 19 Lower Bollinger Band Walk Weakness -0.13%
Sep 19 Multiple of Ten Bearish Other -0.13%

Older signals for MNK ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Mallinckrodt public limited company develops, manufactures, markets, and distributes branded and generic specialty pharmaceuticals, active pharmaceutical ingredients (API), and diagnostic imaging agents worldwide. The company's Specialty Pharmaceuticals segment offers EXALGO extended-release tablets to treat pain in opioid-tolerant patients; and GABLOFEN injections indicated for use in the management of spasticity of cerebral or spinal origin in patients age four years and above. This segment also provides generic drugs, such as oxycodone or in combination with acetaminophen, as well as hydrocodone, which in combination with acetaminophen to treat pain; and methylphenidate to treat attention deficit hyperactivity disorder. This segment markets its branded products to physicians, including pain specialists, anesthesiologists, orthopedic surgeons, rheumatologists, and neurologists; and generic products to wholesalers, large- and medium-sized retail pharmacy chains, food store chains with pharmacies, mail order pharmacies, and other channels of distribution. Its Global Medical Imaging segment provides contrast media and delivery systems comprising iodine- and gadolinium-containing injectable products for diagnostic imaging applications, such as computed tomography and magnetic resonance imaging under the Optiray and Optimark brand names. This segment also offers nuclear imaging agents consisting of Technescan MAG3, a nuclear imaging agent to detect and evaluate a range of renal disorders; technetium-99m for use in Ultra-Technekow DTE generators; cold kits; and other radiopharmaceuticals, such as Octreoscan to detect cancer. This segment sells its contrast media systems to hospitals and hospital groups; branded products directly to managed care organizations; and API products to other pharmaceutical companies. The company was incorporated in 2013 and is based in Dublin, Ireland. Mallinckrodt plc (NYSE:MNK) operates independently of Covidien plc as of June 28, 2013.
Is MNK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 1 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 39.05
52 Week Low 11.65
Average Volume 2,934,867
200-Day Moving Average 20.6845
50-Day Moving Average 29.2892
20-Day Moving Average 32.5525
10-Day Moving Average 30.781
Average True Range 1.1612
ADX 42.91
+DI 14.798
-DI 30.2399
Chandelier Exit (Long, 3 ATRs ) 32.9064
Chandelier Exit (Short, 3 ATRs ) 31.9836
Upper Bollinger Band 36.6705
Lower Bollinger Band 28.4345
Percent B (%b) 0.15
BandWidth 25.300668
MACD Line -0.2277
MACD Signal Line 0.5085
MACD Histogram -0.7361
Fundamentals Value
Market Cap 2.88 Billion
Num Shares 97 Million
EPS -4.63
Price-to-Earnings (P/E) Ratio -6.40
Price-to-Sales 0.92
Price-to-Book 0.59
PEG Ratio 0.79
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 31.02
Resistance 3 (R3) 31.09 30.71 30.79
Resistance 2 (R2) 30.71 30.36 30.67 30.71
Resistance 1 (R1) 30.17 30.14 29.98 30.10 30.64
Pivot Point 29.79 29.79 29.69 29.75 29.79
Support 1 (S1) 29.25 29.44 29.06 29.18 28.64
Support 2 (S2) 28.87 29.22 28.83 28.57
Support 3 (S3) 28.33 28.87 28.49
Support 4 (S4) 28.26